Pharmacology Quiz: Adrenal Insufficiency And Steroid Tapering

20 questions · exam conditions

0:00

Adrenal Insufficiency And Steroid TaperingQuestion 1 of 20

A 55-year-old woman is being tapered off prednisone for giant cell arteritis (GCA). After her dose is reduced from 10 mg to 7.5 mg daily, she develops prominent insomnia, anxiety, and irritability. Her inflammatory markers (ESR, CRP) are normal, and she has no headache, jaw claudication, or vision changes. Which of the following is the most likely cause of her new symptoms?

A flare of her giant cell arteritis.

Glucocorticoid withdrawal syndrome.

Emerging secondary adrenal insufficiency.

Adverse neuropsychiatric effects of the corticosteroid.

← Back to quizzes

Pharmacology Quiz

Pharmacology Quiz: Adrenal Insufficiency And Steroid Tapering

Practice Adrenal Insufficiency And Steroid Tapering in Pharmacology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Adrenal Insufficiency And Steroid Tapering, giving you a quick way to practice the rules, question types, and explanations that matter most for Pharmacology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A flare of her giant cell arteritis.
Glucocorticoid withdrawal syndrome.
Emerging secondary adrenal insufficiency.
Adverse neuropsychiatric effects of the corticosteroid. (correct answer)

Explanation: When evaluating new neuropsychiatric symptoms in patients on corticosteroids, you need to distinguish between withdrawal effects, disease flare, and direct drug effects. The timing and context of symptom onset are crucial clues. This patient's insomnia, anxiety, and irritability developed after a dose reduction but while still on a moderate dose of prednisone (7.5 mg daily). These are classic neuropsychiatric side effects of corticosteroids themselves, which can paradoxically emerge or worsen during tapering as the body adjusts to lower steroid levels. The symptoms represent the brain's response to still-present exogenous corticosteroids, not their absence. Option A is incorrect because her inflammatory markers are normal and she lacks the classic symptoms of GCA flare (headache, jaw claudication, vision changes). Option B represents a common misconception - true glucocorticoid withdrawal syndrome typically occurs when steroids are discontinued entirely or reduced to very low doses, presenting with fatigue, weakness, and malaise rather than these activating symptoms. Option C is wrong because secondary adrenal insufficiency wouldn't cause these specific neuropsychiatric symptoms, and the patient is still on a physiologically significant steroid dose that would suppress her hypothalamic-pituitary-adrenal axis. Study tip: Remember that corticosteroids can cause neuropsychiatric effects at any dose, and these effects can actually become more prominent during tapering as patients become more sensitive to the remaining drug. Always consider direct drug effects when patients develop new symptoms while still on significant corticosteroid doses, especially mood and sleep disturbances.

Question 2

A clinician plans to transition a patient on long-term daily prednisone to an alternate-day therapy (ADT) regimen to minimize HPA axis suppression. Which of the following principles is essential for the successful implementation of ADT?

The total dose for two days is administered as a single morning dose of an intermediate-acting glucocorticoid. (correct answer)
A long-acting glucocorticoid like dexamethasone must be used to provide coverage on the 'off' day.
The patient's daily dose must first be tapered to a physiologic level (e.g., 5 mg) before starting ADT.
The total steroid dose is decreased by 50% by giving the usual daily dose only every other day.

Explanation: When you encounter questions about alternate-day therapy (ADT) for glucocorticoids, focus on the core principle: maximizing the time when exogenous steroids are absent to allow HPA axis recovery while maintaining therapeutic benefit. The correct approach to ADT involves giving the total two-day steroid dose as a single morning dose of an intermediate-acting glucocorticoid every other day. This strategy works because it provides a full 24-hour period when no exogenous steroid is present, allowing the suppressed HPA axis to begin recovering. The morning timing mimics natural cortisol rhythm, and intermediate-acting agents (like prednisone or prednisolone) provide adequate duration without excessive persistence. Looking at the incorrect options: Option B fails because long-acting glucocorticoids like dexamethasone defeat the purpose—their prolonged activity prevents HPA recovery even on "off" days. Option C is unnecessarily restrictive; while lower doses make ADT easier to implement, you don't need to reach physiologic levels first—ADT can be attempted at higher doses too. Option D represents a common misconception—this approach reduces the total steroid exposure by half, potentially causing disease flares, rather than maintaining equivalent dosing in an alternate pattern. Remember this key distinction: ADT maintains the same total drug exposure (just redistributed) while creating steroid-free intervals for HPA recovery. It's not about dose reduction—it's about timing optimization. On pharmacology exams, ADT questions often test whether you understand this redistribution concept versus simple dose tapering.

Question 3

A 70-year-old patient in the ICU with septic shock remains hypotensive with a mean arterial pressure of 55 mmHg despite adequate fluid resuscitation and high-dose norepinephrine. A random cortisol level is 15 mcg/dL. According to current surviving sepsis guidelines, which of the following is the most appropriate next step?

Administer intravenous hydrocortisone. (correct answer)
Perform a high-dose ACTH stimulation test before giving steroids.
The cortisol level is adequate for stress; add vasopressin.
Switch norepinephrine to epinephrine for broader receptor activity.

Explanation: This patient has refractory septic shock. The condition of critical illness-related corticosteroid insufficiency (CIRCI) is suspected when the adrenal glands cannot produce enough cortisol to handle the extreme stress of sepsis. In a patient with refractory shock, guidelines recommend administering IV hydrocortisone (e.g., 200 mg/day). A random cortisol level of 15 mcg/dL in the setting of severe stress is considered inadequate. Treatment should not be delayed for stimulation testing in this unstable patient. While vasopressin is also an option for refractory shock, addressing potential adrenal insufficiency is a key consideration.

Question 4

A patient with an adrenal adenoma has primary hyperaldosteronism. A second patient with 21-hydroxylase deficiency (a form of CAH) is treated with supraphysiologic doses of hydrocortisone. A third patient with Addison's disease is on replacement therapy with hydrocortisone and fludrocortisone. All three patients develop hypertension and hypokalemia. Which mechanism is a primary driver of these signs in the second and third patients but NOT the first?

Autonomous secretion of mineralocorticoids from the adrenal cortex.
Suppression of the renin-angiotensin system via negative feedback.
Excessive stimulation of the adrenal glands by pituitary ACTH.
Exogenous administration of a corticosteroid with mineralocorticoid activity. (correct answer)

Explanation: When analyzing adrenal disorders causing hypertension and hypokalemia, focus on distinguishing between endogenous hormone excess and exogenous medication effects. The correct answer is D because patients 2 and 3 are receiving exogenous corticosteroids. In CAH with 21-hydroxylase deficiency, supraphysiologic hydrocortisone doses are needed to suppress ACTH, but hydrocortisone has significant mineralocorticoid activity at high doses. The Addison's patient receives both hydrocortisone and fludrocortisone (a potent synthetic mineralocorticoid) as replacement therapy. Both scenarios involve direct administration of drugs with mineralocorticoid effects. Patient 1, however, has endogenous aldosterone excess from the adenoma itself. Option A is incorrect because it describes patient 1's pathophysiology (autonomous aldosterone secretion), not patients 2 and 3 who have exogenous steroid administration. Option B occurs in all three patients as a consequence of mineralocorticoid excess, regardless of source. High mineralocorticoid activity suppresses renin through volume expansion and isn't unique to patients 2 and 3. Option C is wrong because patient 1 doesn't have excessive ACTH stimulation—the adenoma works independently. Patient 2 initially has high ACTH (due to cortisol deficiency) but treatment aims to suppress it. Patient 3 has low ACTH due to adrenal failure. Remember: In pharmacology questions about steroid disorders, always distinguish between endogenous hormone problems and iatrogenic effects from medications. Many corticosteroids have cross-reactivity with mineralocorticoid receptors, especially at higher doses.

Question 5

A 60-year-old male with severe alcoholic cirrhosis (Child-Pugh Class C) is diagnosed with severe alcoholic hepatitis, for which high-dose corticosteroid therapy is indicated. Which of the following is the most appropriate therapeutic choice for this patient?

Prednisone, because it has the most evidence for this indication.
Prednisolone, because its activation does not depend on hepatic metabolism. (correct answer)
Dexamethasone, to minimize fluid retention due to its lack of mineralocorticoid effect.
Hydrocortisone, because it has the shortest half-life in patients with liver failure.

Explanation: Prednisone is a prodrug that requires hepatic conversion to its active metabolite, prednisolone. In patients with severe liver dysfunction, this conversion can be significantly impaired, leading to sub-therapeutic drug levels. Therefore, administering the active form, prednisolone, directly is the preferred approach to ensure adequate bioavailability. While dexamethasone and hydrocortisone are also steroids, prednisolone is the agent with the most robust clinical trial evidence for improving short-term mortality in severe alcoholic hepatitis.

Question 6

A patient is being tapered from long-term prednisone therapy. The dose has been successfully reduced from 40 mg/day to 5 mg/day over several months. What is the primary physiological reason for significantly slowing the rate of tapering once the dose reaches the physiologic range (e.g., ≤ 5 mg prednisone)?

To prevent the recurrence of the underlying inflammatory condition being treated.
To allow the hypothalamic-pituitary-adrenal axis sufficient time to recover function. (correct answer)
To mitigate psychological dependence on the glucocorticoid medication.
To reduce the cumulative risk of developing iatrogenic Cushing's syndrome.

Explanation: When tapering glucocorticoids, the rate changes based on the dose. At supraphysiologic doses (>7.5 mg prednisone equivalent), the main concern is preventing a flare of the underlying disease. Once the dose enters the physiologic range (the amount the body would normally produce), the primary goal shifts to allowing the suppressed HPA axis to recover. The adrenal glands have atrophied, and the hypothalamus/pituitary have downregulated production of CRH/ACTH. A very slow taper is needed to give the axis time to regain its ability to produce endogenous cortisol.

Question 7

A patient with panhypopituitarism resulting from a non-secreting pituitary macroadenoma is diagnosed with secondary adrenal insufficiency. Which medication regimen is the most appropriate long-term replacement therapy for this specific condition?

Hydrocortisone daily and fludrocortisone daily.
Fludrocortisone daily, with as-needed hydrocortisone.
Cosyntropin (ACTH) injections to stimulate the adrenal glands.
Hydrocortisone daily, with education on stress dosing. (correct answer)

Explanation: When you encounter questions about adrenal insufficiency, the key distinction is between primary (adrenal gland failure) and secondary (pituitary ACTH deficiency). This fundamentally changes your replacement therapy approach. In secondary adrenal insufficiency from panhypopituitarism, the adrenal glands themselves are healthy—they're simply not receiving ACTH stimulation from the damaged pituitary. The zona fasciculata (which produces cortisol under ACTH control) is affected, but the zona glomerulosa (which produces aldosterone under renin-angiotensin control) remains functional. This means patients need glucocorticoid replacement but typically maintain normal mineralocorticoid function. Answer D is correct because hydrocortisone provides essential glucocorticoid replacement, and stress dosing education is crucial—during illness, surgery, or stress, cortisol needs increase dramatically, and patients must know to increase their dose to prevent adrenal crisis. Answer A incorrectly includes fludrocortisone (mineralocorticoid), which isn't needed since aldosterone production remains intact in secondary adrenal insufficiency. Answer B makes the same mineralocorticoid error and dangerously suggests "as-needed" hydrocortisone—glucocorticoid replacement must be continuous, not intermittent. Answer C suggests cosyntropin (synthetic ACTH), but this won't work long-term since the underlying problem is lack of endogenous ACTH from the damaged pituitary. Remember this pattern: Primary adrenal insufficiency requires both glucocorticoid and mineralocorticoid replacement, while secondary adrenal insufficiency typically needs only glucocorticoid replacement. Always ensure patients understand stress dosing protocols to prevent life-threatening adrenal crises.

Question 8

A patient is in an adrenal crisis of unknown etiology. The team administers IV fluids and a STAT dose of a corticosteroid. Why is hydrocortisone generally preferred over dexamethasone for the initial management of an adrenal crisis when the specific type of insufficiency is not yet known?

Dexamethasone has a longer half-life, which complicates dose titration in the acute setting.
Hydrocortisone has a more potent anti-inflammatory effect on a milligram-per-milligram basis.
Hydrocortisone provides both glucocorticoid and clinically significant mineralocorticoid activity. (correct answer)
Dexamethasone is more likely to cause psychiatric side effects during acute administration.

Explanation: Adrenal crisis, particularly from primary adrenal insufficiency, involves a profound deficiency of both cortisol (a glucocorticoid) and aldosterone (a mineralocorticoid). This leads to both shock and severe electrolyte disturbances. Hydrocortisone is preferred for initial management because it possesses both glucocorticoid and mineralocorticoid activity, addressing both deficiencies simultaneously. Dexamethasone is a pure glucocorticoid with negligible mineralocorticoid effects, so it would not correct the hyperkalemia, hyponatremia, and volume depletion caused by aldosterone deficiency.

Question 9

A patient stabilized on oral prednisone 20 mg daily for systemic lupus erythematosus develops severe vomiting and cannot tolerate oral medications. The physician decides to switch to an intravenous formulation. Which of the following IV regimens provides a glucocorticoid effect approximately equivalent to 20 mg of oral prednisone?

Hydrocortisone 40 mg IV daily.
Methylprednisolone 16 mg IV daily. (correct answer)
Dexamethasone 7.5 mg IV daily.
Triamcinolone 20 mg IV daily.

Explanation: This question requires knowledge of corticosteroid dose equivalencies. The approximate equivalencies are: Prednisone 5 mg = Methylprednisolone 4 mg = Hydrocortisone 20 mg = Dexamethasone 0.75 mg. To find the equivalent dose for 20 mg of prednisone: (20 mg prednisone / 5 mg prednisone) * 4 mg methylprednisolone = 16 mg methylprednisolone. Hydrocortisone 80 mg (not 40 mg), and dexamethasone 3 mg (not 7.5 mg) would be equivalent. Triamcinolone is generally not administered intravenously.

Question 10

A 32-year-old patient with ulcerative colitis on prednisone 40 mg/day for 6 months abruptly discontinues the medication. Three days later, she presents to the emergency department with severe abdominal pain, vomiting, fever of 39°C, and a blood pressure of 80/50 mmHg. Laboratory results show a sodium of 128 mEq/L and a potassium of 5.6 mEq/L. Which of the following is the most critical initial intervention?

Administer a cosyntropin stimulation test to confirm adrenal insufficiency.
Administer intravenous hydrocortisone and 0.9% saline. (correct answer)
Obtain blood cultures and administer broad-spectrum antibiotics.
Restart oral prednisone at her previous dose of 40 mg/day.

Explanation: This patient is presenting with a classic adrenal crisis (hypotension, fever, GI symptoms, hyponatremia, hyperkalemia) due to abrupt cessation of long-term steroids. This is a medical emergency. The most critical intervention is immediate fluid resuscitation with normal saline and administration of stress-dose intravenous glucocorticoids (hydrocortisone is preferred for its mineralocorticoid activity). Delaying treatment for diagnostic testing or starting antibiotics first (while important if sepsis is suspected) would be life-threatening. The oral route is contraindicated due to vomiting and shock.

Question 11

A 62-year-old female on chronic dexamethasone 0.5 mg daily for a brain tumor develops fatigue, nausea, and orthostasis. An early morning cortisol level is <1 mcg/dL. An ACTH stimulation test is performed, showing a baseline cortisol of 0.8 mcg/dL and a 30-minute post-cosyntropin cortisol of 1.2 mcg/dL. How should these findings be interpreted?

Primary adrenal insufficiency (Addison's disease).
Secondary adrenal insufficiency due to a pituitary lesion.
Tertiary adrenal insufficiency due to chronic glucocorticoid therapy. (correct answer)
A normal adrenal response expected in a patient on long-term steroid therapy.

Explanation: The patient's history of chronic dexamethasone use is the key. Exogenous glucocorticoids suppress the hypothalamus's release of CRH, which in turn suppresses the pituitary's release of ACTH, leading to adrenal atrophy. This is tertiary (hypothalamic-driven) or secondary (pituitary-driven) insufficiency; functionally, iatrogenic suppression affects the whole axis. The ACTH stimulation test shows a blunted response (no significant rise in cortisol), confirming that the adrenal glands are atrophied and unable to respond. This entire picture is characteristic of adrenal insufficiency caused by long-term exogenous steroid use.

Question 12

A 58-year-old male with rheumatoid arthritis, managed with prednisone 10 mg daily for the past 3 years, is scheduled for an elective total knee arthroplasty. His last dose of prednisone was this morning. Which of the following is the most appropriate perioperative corticosteroid management plan?

Continue his usual 10 mg oral prednisone dose on the day of surgery and post-operatively.
Administer a single dose of ACTH (cosyntropin) pre-operatively to stimulate endogenous cortisol production.
Administer hydrocortisone 100 mg IV prior to surgical incision, followed by scheduled doses for 24-48 hours. (correct answer)
Hold prednisone for 48 hours pre-operatively to reduce wound healing complications and infection risk.

Explanation: The patient has been on a suppressive dose of prednisone (>5 mg/day) for more than 3 weeks, so he is presumed to have hypothalamic-pituitary-adrenal (HPA) axis suppression. He will be unable to mount an adequate endogenous cortisol response to the major stress of surgery. The standard of care is to provide 'stress-dose' steroids. Hydrocortisone 100 mg IV is a typical dose for major surgery, followed by scheduled doses (e.g., 50 mg IV every 8 hours) for 24-48 hours before tapering back to his baseline oral dose.

Question 13

A patient with Crohn's disease has been tapered off a 6-week course of prednisone 40 mg daily. Two days after the final dose, he reports diffuse myalgias, lethargy, and anorexia. His blood pressure is 118/76 mmHg, serum sodium is 138 mEq/L, and his Crohn's symptoms have not returned. Which of the following best explains his current symptoms?

Acute adrenal insufficiency.
A flare of his underlying Crohn's disease.
Glucocorticoid withdrawal syndrome. (correct answer)
Subclinical Cushing's syndrome from recent therapy.

Explanation: Glucocorticoid withdrawal syndrome is characterized by non-specific symptoms like myalgia, arthralgia, fatigue, and anorexia after steroid discontinuation. It is distinguished from true adrenal insufficiency by the absence of hypotension or significant electrolyte abnormalities. The patient's stable vital signs and normal sodium level make acute adrenal insufficiency less likely. The stem specifies his Crohn's symptoms have not flared, and Cushing's syndrome is a state of glucocorticoid excess, not withdrawal.

Question 14

Acute adrenal insufficiency.
A flare of his underlying Crohn's disease.
Glucocorticoid withdrawal syndrome. (correct answer)
Subclinical Cushing's syndrome from recent therapy.

Question 15

A 45-year-old female was treated with prednisone 60 mg/day for 10 days for a severe poison ivy rash. Her rash has resolved completely. Which of the following is the most appropriate next step regarding the prednisone?

Discontinue the medication without a taper. (correct answer)
Taper the dose by 10 mg every other day over 12 days.
Switch to topical hydrocortisone for one week then stop.
Perform a low-dose ACTH stimulation test before discontinuation.

Explanation: Significant HPA axis suppression is unlikely with courses of glucocorticoids lasting less than 3 weeks, regardless of the dose. Therefore, a 10-day course of prednisone, even at a high dose, can be stopped abruptly without a taper once the underlying condition is resolved. Tapering or performing diagnostic tests is unnecessary.

Question 16

A 68-year-old male with polymyalgia rheumatica (PMR) has been on prednisone 15 mg daily for 8 months. His symptoms are well-controlled. During a taper, the dose is reduced to 12.5 mg daily. One week later, he reports a return of severe morning stiffness and shoulder pain, identical to his initial presentation. An 8 AM cortisol level is < 1 mcg/dL. What is the most likely cause of his symptoms?

Acute adrenal crisis precipitated by the dose reduction.
Recurrence of underlying polymyalgia rheumatica. (correct answer)
Glucocorticoid withdrawal syndrome unrelated to his PMR.
Development of steroid-induced myopathy.

Explanation: The patient's symptoms (severe morning stiffness, shoulder pain) are highly specific to his underlying PMR. This indicates that the reduced prednisone dose (12.5 mg) is now sub-therapeutic for controlling the inflammation of his disease. While he has confirmed HPA axis suppression (low cortisol), his symptoms are not typical of an adrenal crisis (e.g., hypotension, shock) or non-specific withdrawal syndrome. The most likely explanation is a disease flare due to an insufficient anti-inflammatory dose.

Question 17

To prevent the recurrence of the underlying inflammatory condition being treated.
To allow the hypothalamic-pituitary-adrenal axis sufficient time to recover function. (correct answer)
To mitigate psychological dependence on the glucocorticoid medication.
To reduce the cumulative risk of developing iatrogenic Cushing's syndrome.

Question 18

A clinician is designing a prednisone taper for a patient who has been on 20 mg daily for 4 months. Which of the following schedules best reflects established principles for minimizing both HPA axis suppression and disease flare?

Decrease by 5 mg every 3 days until the dose is discontinued.
Maintain 20 mg on weekdays and hold the dose on weekends to 'rest' the HPA axis.
Decrease by 2.5 mg every 1-2 weeks until 10 mg, then by 1 mg every 2-4 weeks thereafter. (correct answer)
Switch to an equivalent dose of dexamethasone and decrease by 0.25 mg every week.

Explanation: A standard, safe tapering principle involves making larger, faster reductions at higher (supraphysiologic) doses and smaller, slower reductions at lower (near-physiologic) doses. The schedule in C reflects this, with 2.5 mg decrements initially, slowing to 1 mg decrements once the dose is lower. This allows for careful monitoring of disease activity while giving the HPA axis maximal time to recover as the dose approaches zero. A is too fast. B is not a recognized tapering method. D is incorrect as switching to a more potent, longer-acting steroid like dexamethasone can make HPA recovery more difficult.

Question 19

A flare of her giant cell arteritis.
Glucocorticoid withdrawal syndrome.
Emerging secondary adrenal insufficiency.
Adverse neuropsychiatric effects of the corticosteroid. (correct answer)

Question 20

Administer intravenous hydrocortisone. (correct answer)
Perform a high-dose ACTH stimulation test before giving steroids.
The cortisol level is adequate for stress; add vasopressin.
Switch norepinephrine to epinephrine for broader receptor activity.